Ego and John Bull: why AZ-Pfizer might falter
This article was originally published in Scrip
Executive Summary
So it's official: Pfizer has bid to acquire AstraZeneca. The terms of an offer made back in January 2014, valuing AstraZeneca at just under $100bn, have now been made public (scripintelligence.com, 28 April 2014).